Lehne's Pharmacology for Nursing Care 9th Edition by Jacqueline Burchum
Lehne's Pharmacology for Nursing Care 9th Edition by Jacqueline Burchum
$2.99
Chapter 49: Antidysrhythmic Drugs
Complete Chapter Questions With Answers
Sample Questions Are Posted Below
MULTIPLE CHOICE
| a. | Beta blockers and calcium channel blockers |
| b. | Beta blockers and potassium channel blockers |
| c. | Calcium channel blockers and sodium channel blockers |
| d. | Sodium channel blockers and potassium channel blockers |
ANS: A
Calcium channel blockade has the same impact on cardiac action potentials as does beta blockade, so these agents have nearly identical effects on cardiac function; that is, they reduce automaticity in the SA node, delay conduction through the AV node, and reduce myocardial contractility. Potassium channel blockers act by delaying repolarization of fast potentials. Sodium channel blockers block sodium channels to slow impulse conduction in the atria, ventricles, and His-Purkinje system.
PTS: 1 DIF: Cognitive Level: Comprehension REF: pp. 538-539
TOP: Nursing Process: Assessment
MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies
| a. | “Drugs that treat ventricular dysrhythmias help to restore normal sinus rhythm.” |
| b. | “Atrial dysrhythmias can have life-threatening effects on ventricular function.” |
| c. | “Treating ventricular dysrhythmias helps prevent the likelihood of stroke.” |
| d. | “When ventricular contraction slows, atrial contraction is also slowed.” |
ANS: B
Dysrhythmic activity in the atria does not significantly reduce cardiac output but can be dangerous when dysrhythmic impulses cross the AV node, causing ventricular dysrhythmias, which can be life threatening. Treating ventricular dysrhythmia helps improve ventricular pumping. These drugs do not restore normal sinus rhythm. To prevent stroke, an anticoagulant, such as warfarin, is used. Slowing ventricular contraction does not affect the rate of atrial contraction. Restoring normal sinus rhythm requires cardioversion, short-term treatment with amiodarone or sotalol, or RF ablation of the dysrhythmia source.
PTS: 1 DIF: Cognitive Level: Application REF: p. 540
TOP: Nursing Process: Planning
MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies
| a. | “I may need long-term therapy with another cardiac medication after the procedure.” |
| b. | “I should stop taking warfarin a few days before the procedure.” |
| c. | “I will need to take a beta blocker after the procedure to prevent recurrence of atrial flutter.” |
| d. | “I will not have to take antidysrhythmia medications after the procedure.” |
ANS: A
After cardioversion for atrial flutter, patients may continue to need long-term therapy with either a class IC agent or a class III agent to prevent recurrence. Patients undergoing DC cardioversion need to take warfarin 3 to 4 weeks before the procedure and for several weeks afterward. Beta blockers are not indicated for postprocedural prophylaxis. Class IC and class III agents are antidysrhythmic drugs.
PTS: 1 DIF: Cognitive Level: Application REF: pp. 540-541
TOP: Nursing Process: Planning
MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies
| a. | “Antidysrhythmic drugs can cause new dysrhythmias or worsen existing ones.” |
| b. | “Adverse effects of these drugs are mainly noncardiac in nature.” |
| c. | “For most antidysrhythmic drugs, there is evidence of reduced mortality.” |
| d. | “Use of these drugs may be necessary even if the benefits are unknown.” |
ANS: A
Because antidysrhythmic drugs have prodysrhythmic actions, they can exacerbate existing dysrhythmias or generate new ones. Most adverse effects are cardiac related. There is evidence of increased mortality with many of these drugs. Use of these drugs should be limited to situations in which there is a clear benefit and only if that benefit outweighs any risks.
PTS: 1 DIF: Cognitive Level: Analysis REF: pp. 541-542
TOP: Nursing Process: Implementation
MSC: NCLEX Client Needs Category: Physiologic Integrity: Reduction of Risk Potential
$40.00 Original price was: $40.00.$20.00Current price is: $20.00.
$100.00 Original price was: $100.00.$75.00Current price is: $75.00.
$30.00 Original price was: $30.00.$20.00Current price is: $20.00.
$499.00 Original price was: $499.00.$49.00Current price is: $49.00.
$40.00 Original price was: $40.00.$30.00Current price is: $30.00.
511 SW 10th Ave 1206, Portland, OR, United States